CareFusion to sell ResMed ventilators in U.S.

When Kieran Gallahue quit as CEO of medical device company ResMed to go to another San Diego device company, CareFusion, 6 months ago, he apparently meant it when he said the parting was amicable. ResMed has given CareFusion permission to sell ResMed's ventilators to U.S. hospitals and nursing homes for the next 5 years. It will be the first time ResMed's device will be available in the United States. What ResMed gets out of it is use of CareFusion's extensive sales network.

The deal revolves around ResMed's Stellar 100 and 150 non-invasive ventilators for adult and pediatric patients. The products have been sold in Asia and Europe for a few years, but until now ResMed's U.S. products were limited to its sleep apnea machines, according to the San Diego Union Tribune.

"The addition of ResMed's Stellar ventilator fills an important need in the respiratory care market segment for our customers," Tony Lopez, senior vice president and general manager of respiratory care at CareFusion, said in a statement. "This strategic agreement also directly aligns with our mission to improve health care costs and quality care to patients."

- read more in the San Diego Union Tribune
- and here's the release

Suggested Articles

AI-based drug molecule designer XtalPi has secured a mammoth funding round totaling $318.8 million, from global banking and tech investors.

LabCorp has licensed a blood test from Genfit designed to identify patients with risky cases of the liver disease NASH.

Philips has launched a compact, single-use device for physically clearing potentially dangerous blood clots lodged in the arms and legs.